Cargando…
Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis
OBJECTIVE: To determine how cohorting patients based on presenting complaints affects risk of nosocomial infection in crowded Emergency Departments (EDs) under conditions of high and low prevalence of COVID-19. METHODS: This was a retrospective analysis of presenting complaints and PCR tests collect...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818126/ https://www.ncbi.nlm.nih.gov/pubmed/35220142 http://dx.doi.org/10.1016/j.ajem.2022.01.070 |
_version_ | 1784645766039470080 |
---|---|
author | Bijur, Polly E. Friedman, Benjamin W. Baron, Sarah W. Ramasahayam, Abhiram Nerenberg, Rebecca Sharpe, Shellyann Goldstein, D. Yitzchak Esses, David |
author_facet | Bijur, Polly E. Friedman, Benjamin W. Baron, Sarah W. Ramasahayam, Abhiram Nerenberg, Rebecca Sharpe, Shellyann Goldstein, D. Yitzchak Esses, David |
author_sort | Bijur, Polly E. |
collection | PubMed |
description | OBJECTIVE: To determine how cohorting patients based on presenting complaints affects risk of nosocomial infection in crowded Emergency Departments (EDs) under conditions of high and low prevalence of COVID-19. METHODS: This was a retrospective analysis of presenting complaints and PCR tests collected during the COVID-19 epidemic from 4 EDs from a large hospital system in Bronx County, NY, from May 1, 2020 to April 30, 2021. Sensitivity, specificity, positive and negative predictive value (PPV, NPV) were calculated for a symptom screen based on the CDC list of COVID-19 symptoms: fever/chills, shortness of breath/dyspnea, cough, muscle or body ache, fatigue, headache, loss of taste or smell, sore throat, nasal congestion/runny nose, nausea, vomiting, and diarrhea. PPV was calculated for varying values of prevalence. RESULTS: There were 80,078 visits with PCR tests. The sensitivity of the symptom screen was 64.7% (95% CI: 63.6, 65.8), specificity 65.4% (65.1, 65.8). PPV was 16.8% (16.5, 17.0) and NPV was 94.5% (94.4, 94.7) when the observed prevalence of COVID-19 in the ED over the year was 9.7%. The PPV of fever/chills, cough, body and muscle aches and nasal congestion/runny nose were each approximately 25% across the year, while diarrhea, nausea, vomiting and headache were less predictive, (PPV 4.7%–9.6%) The combinations of fever/chills, cough, muscle/body aches, and shortness of breath had PPVs of 40–50%. The PPV of the screen varied from 3.7% (3.6, 3.8) at 2% prevalence of COVID-19 to 44.3% (44.0, 44.7) at 30% prevalence. CONCLUSION: The proportion of patients with a chief complaint of COVID-19 symptoms and confirmed COVID-19 infection was exceeded by the proportion without actual infection. This was true when prevalence in the ED was as high as 30%. Cohorting of patients based on the CDC's list of COVID-19 symptoms will expose many patients who do not have COVID-19 to risk of nosocomially acquired COVID-19. EDs should not use the CDC list of COVID-19 symptoms as the only strategy to minimize exposure. |
format | Online Article Text |
id | pubmed-8818126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88181262022-02-07 Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis Bijur, Polly E. Friedman, Benjamin W. Baron, Sarah W. Ramasahayam, Abhiram Nerenberg, Rebecca Sharpe, Shellyann Goldstein, D. Yitzchak Esses, David Am J Emerg Med Article OBJECTIVE: To determine how cohorting patients based on presenting complaints affects risk of nosocomial infection in crowded Emergency Departments (EDs) under conditions of high and low prevalence of COVID-19. METHODS: This was a retrospective analysis of presenting complaints and PCR tests collected during the COVID-19 epidemic from 4 EDs from a large hospital system in Bronx County, NY, from May 1, 2020 to April 30, 2021. Sensitivity, specificity, positive and negative predictive value (PPV, NPV) were calculated for a symptom screen based on the CDC list of COVID-19 symptoms: fever/chills, shortness of breath/dyspnea, cough, muscle or body ache, fatigue, headache, loss of taste or smell, sore throat, nasal congestion/runny nose, nausea, vomiting, and diarrhea. PPV was calculated for varying values of prevalence. RESULTS: There were 80,078 visits with PCR tests. The sensitivity of the symptom screen was 64.7% (95% CI: 63.6, 65.8), specificity 65.4% (65.1, 65.8). PPV was 16.8% (16.5, 17.0) and NPV was 94.5% (94.4, 94.7) when the observed prevalence of COVID-19 in the ED over the year was 9.7%. The PPV of fever/chills, cough, body and muscle aches and nasal congestion/runny nose were each approximately 25% across the year, while diarrhea, nausea, vomiting and headache were less predictive, (PPV 4.7%–9.6%) The combinations of fever/chills, cough, muscle/body aches, and shortness of breath had PPVs of 40–50%. The PPV of the screen varied from 3.7% (3.6, 3.8) at 2% prevalence of COVID-19 to 44.3% (44.0, 44.7) at 30% prevalence. CONCLUSION: The proportion of patients with a chief complaint of COVID-19 symptoms and confirmed COVID-19 infection was exceeded by the proportion without actual infection. This was true when prevalence in the ED was as high as 30%. Cohorting of patients based on the CDC's list of COVID-19 symptoms will expose many patients who do not have COVID-19 to risk of nosocomially acquired COVID-19. EDs should not use the CDC list of COVID-19 symptoms as the only strategy to minimize exposure. Elsevier Inc. 2022-04 2022-02-06 /pmc/articles/PMC8818126/ /pubmed/35220142 http://dx.doi.org/10.1016/j.ajem.2022.01.070 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bijur, Polly E. Friedman, Benjamin W. Baron, Sarah W. Ramasahayam, Abhiram Nerenberg, Rebecca Sharpe, Shellyann Goldstein, D. Yitzchak Esses, David Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis |
title | Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis |
title_full | Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis |
title_fullStr | Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis |
title_full_unstemmed | Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis |
title_short | Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis |
title_sort | should covid-19 symptoms be used to cohort patients in the emergency department? a retrospective analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818126/ https://www.ncbi.nlm.nih.gov/pubmed/35220142 http://dx.doi.org/10.1016/j.ajem.2022.01.070 |
work_keys_str_mv | AT bijurpollye shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis AT friedmanbenjaminw shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis AT baronsarahw shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis AT ramasahayamabhiram shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis AT nerenbergrebecca shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis AT sharpeshellyann shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis AT goldsteindyitzchak shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis AT essesdavid shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis |